These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26989871)

  • 21. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy].
    Ring J; Lonsdorf G; Schury W; Burg G
    MMW Munch Med Wochenschr; 1982 Jun; 124(24):587-90. PubMed ID: 6810134
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapy for allergy to insect stings.
    Lockey RF
    N Engl J Med; 1990 Dec; 323(23):1627-8. PubMed ID: 2233953
    [No Abstract]   [Full Text] [Related]  

  • 23. A Case Study in Health Disparities: Barriers to Immunotherapy for Venom-Induced Anaphylaxis.
    Satyavarapu I; Hein N; Carlson JC
    J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2568-2569. PubMed ID: 37301432
    [No Abstract]   [Full Text] [Related]  

  • 24. [Bee venom immunotherapy: whom to treat with which regiment for how long?].
    Díez Gómez AM
    Allergol Immunopathol (Madr); 1995; 23(6):256-62. PubMed ID: 8579002
    [No Abstract]   [Full Text] [Related]  

  • 25. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venom immunotherapy: pitfalls and open questions.
    Aberer W; Sturm G
    Immunotherapy; 2011 Nov; 3(11):1277-9. PubMed ID: 22053877
    [No Abstract]   [Full Text] [Related]  

  • 27. [The significance of desensitization therapy].
    Ned Tijdschr Geneeskd; 1991 Mar; 135(12):532-5. PubMed ID: 2027400
    [No Abstract]   [Full Text] [Related]  

  • 28. [Desensitization of allergy to hymenoptera venoms].
    Przybilla B; Ruëff F
    Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What's eating you? Bees, Part 2: Venom immunotherapy and mastocytosis.
    Lewis FS; Smith LJ
    Cutis; 2007 Jul; 80(1):33-7. PubMed ID: 17725061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab.
    Galera C; Soohun N; Zankar N; Caimmi S; Gallen C; Demoly P
    J Investig Allergol Clin Immunol; 2009; 19(3):225-9. PubMed ID: 19610266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy control of specific hymenoptera venom allergy].
    Aust W; Wichmann G; Dietz A
    Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in gene expression caused by insect venom immunotherapy responsible for the long-term protection of insect venom-allergic patients.
    Niedoszytko M; Bruinenberg M; de Monchy J; Weersma RK; Wijmenga C; Jassem E; Elberink JN
    Ann Allergy Asthma Immunol; 2011 Jun; 106(6):502-10. PubMed ID: 21624750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jessner lymphocytic infiltrate as a side effect of bee venom immunotherapy.
    Yalcin AD; Bisgin A; Akman A; Erdogan G; Ciftcioglu MA; Yegin O
    J Investig Allergol Clin Immunol; 2012; 22(4):308-9. PubMed ID: 22812210
    [No Abstract]   [Full Text] [Related]  

  • 34. The value of immunotherapy with venom in children with allergy to insect stings.
    Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
    N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines.
    Fiedler C; Miehe U; Treudler R; Kiess W; Prenzel F
    Int Arch Allergy Immunol; 2017; 172(3):167-172. PubMed ID: 28380475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hymenoptera venom allergy in humans.
    Cichocka-Jarosz E
    Folia Med Cracov; 2012; 52(3-4):43-60. PubMed ID: 24852686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
    Ruiz B; Serrano P; Moreno C
    J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The key role of IgG4 subclass antibodies in the development of protection against allergic reactions to insect stings].
    Urbanek R; Dold S
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):536-40. PubMed ID: 3773921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.